Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.

Acta neurochirurgica - 1 Aug 2022

Krigers Aleksandrs, Demetz Matthias, Grams Astrid E, Thomé Claudius, Freyschlag Christian F

Abstract excerpt

PURPOSE: We evaluated differentiations in gadolinium contrast enhancement (CE) between low-grade WHO °II and high-grade WHO °III gliomas in conventional MRI, which have been repeatedly questioned. METHODS: Ninety-nine patients, who underwent first resection of WHO°II and °III gliomas, were retrospectively retrieved from a prospective database. The quantitative metric volume of Gd-CE in T1-weighted pre-operative...

Topics

Join the communities discussing this publication.

Brain Neoplasms
Glioma
Isocitrate Dehydrogenase
Magnetic Resonance Imaging
Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35018531
DOI: 10.1007/s00701-021-05103-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.PMID 35018531Read ↗

Feasibility of Evaluating the Histologic and Genetic Subtypes of WHO Grade II-IV Gliomas by Diffusion-Weighted ImagingSemantic proximity Read ↗

Relevance of calcification and contrast enhancement pattern for molecular diagnosis and survival prediction of gliomas based on the 2016 World Health Organization Classification.Semantic proximity Read ↗

Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas.Semantic proximity Read ↗

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.Semantic proximity Read ↗

IDH status shapes glioma oncotopy: voxel-wise mapping of 644 adult diffuse gliomas.Semantic proximity Read ↗

Rethinking extent of resection of contrast-enhancing and non-enhancing tumor: different survival impacts on adult-type diffuse gliomas in 2021 World Health Organization classification.Semantic proximity Read ↗

Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.Semantic proximity Read ↗

Tumor volume and calcifications as indicators for preoperative differentiation of grade II/III diffuse gliomas.Semantic proximity Read ↗

Looking through the imaging perspective: the importance of imaging necrosis in glioma diagnosis and prognostic predictionSemantic proximity Read ↗

Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas.Semantic proximity Read ↗

Visual versus region-of-interest based diffusion evaluation and their diagnostic impact in adult-type diffuse gliomas.Semantic proximity Read ↗

Association of a diffuse phenotype on MRI with shorter overall survival in patients with astrocytoma CNS WHO grades 2 and 3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.